Core Insights - 康哲药业 successfully held a forum and appreciation dinner in Singapore to celebrate its secondary listing on the Singapore Exchange, gathering nearly 150 industry leaders and stakeholders [1][3] - The forum focused on the development of the pharmaceutical industry in Singapore and emerging markets, discussing strategies for internationalization and commercialization of innovative drugs [3][5] Industry Overview - Emerging markets, including Asia-Pacific, India, Africa & Middle East, and Latin America, are projected to reach a pharmaceutical market size of $336 to $384 billion by 2028, nearing the $410 billion expected for Western Europe [5] - Singapore is positioned as a hub for capital and innovation, with a shift from traditional third-party logistics to more integrated commercial strategies being essential for sustainable success in Southeast Asia [5] Company Strategy - 康哲药业 aims to expand its strategic vision across the Asia-Pacific market, leveraging its established resources in China and using Singapore as a regional hub to drive innovation through a comprehensive "research-production-sales-investment" model [6][8] - The company has introduced its international business cluster, highlighting its PharmaGend factory, which aims to become the largest and most trusted CMO/CDMO in Southeast Asia, with a production area of approximately 30,000 square meters and dual certifications from the FDA and HSA [8] Innovation and Development - 康哲药业 is establishing a global incubation platform for early-stage biopharmaceutical innovations through its HiGend initiative, enhancing the efficiency of global drug development [9] - The company is also setting up the CMS R&D Institute in 2024, focusing on early-stage innovative drugs, aiming to synchronize "China speed" with global standards [8][9] Market Exploration - Chinese pharmaceutical companies are increasingly exploring emerging markets, with over $10 billion in upfront payments from licensing deals in the past three years, primarily focused on mature markets [11] - The need for a comprehensive internationalization strategy that integrates research, production, and sales is emphasized for sustainable growth in new markets [12]